11-44048448-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001363113.1(ACCSL):c.-179C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000298 in 1,613,420 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000031 ( 0 hom. )
Consequence
ACCSL
NM_001363113.1 5_prime_UTR_premature_start_codon_gain
NM_001363113.1 5_prime_UTR_premature_start_codon_gain
Scores
5
8
6
Clinical Significance
Conservation
PhyloP100: 2.12
Genes affected
ACCSL (HGNC:34391): (1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like) Predicted to enable catalytic activity and pyridoxal phosphate binding activity. Predicted to be involved in biosynthetic process. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.89
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACCSL | NM_001031854.2 | c.412C>T | p.Arg138Cys | missense_variant | 1/14 | ENST00000378832.1 | NP_001027025.2 | |
ACCSL | NM_001363113.1 | c.-179C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/14 | NP_001350042.1 | |||
ACCSL | XM_047426927.1 | c.460C>T | p.Arg154Cys | missense_variant | 5/18 | XP_047282883.1 | ||
ACCSL | NM_001363113.1 | c.-179C>T | 5_prime_UTR_variant | 1/14 | NP_001350042.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACCSL | ENST00000378832.1 | c.412C>T | p.Arg138Cys | missense_variant | 1/14 | 1 | NM_001031854.2 | ENSP00000368109.1 | ||
ACCSL | ENST00000527145.1 | n.412C>T | non_coding_transcript_exon_variant | 1/14 | 1 | ENSP00000436505.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151542Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
151542
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000321 AC: 8AN: 249446Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135342
GnomAD3 exomes
AF:
AC:
8
AN:
249446
Hom.:
AF XY:
AC XY:
4
AN XY:
135342
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461878Hom.: 0 Cov.: 32 AF XY: 0.0000358 AC XY: 26AN XY: 727242
GnomAD4 exome
AF:
AC:
46
AN:
1461878
Hom.:
Cov.:
32
AF XY:
AC XY:
26
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151542Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 73954
GnomAD4 genome
AF:
AC:
2
AN:
151542
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
73954
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
5
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 23, 2021 | The c.412C>T (p.R138C) alteration is located in exon 1 (coding exon 1) of the ACCSL gene. This alteration results from a C to T substitution at nucleotide position 412, causing the arginine (R) at amino acid position 138 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Pathogenic
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
PrimateAI
Benign
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at